An update on the human and animal enteric pathogen Clostridium perfringens Original paper

What was reviewed?

This review examined the genomic features, virulence mechanisms, microbiome interactions, and clinical significance of Clostridium perfringens as a gastrointestinal organism that exists both as a commensal microbiome member and as a toxin-producing pathogen. The authors focused on toxin production, plasmid-mediated virulence, antimicrobial resistance, sporulation, and microbiome colonization mechanisms, highlighting how genomic diversity and environmental conditions influence pathogenic transition. The review also emphasized the role of modern genomic sequencing and microbiome profiling in understanding strain variation, transmission, and disease associations across human and animal hosts.

Who was reviewed?

The review analyzed microbiome, genomic, and clinical studies involving Clostridium perfringens isolates from human gastrointestinal microbiomes, hospitalized adults, pre-term infants, livestock, poultry, and environmental sources. These included metagenomic microbiome studies demonstrating increased C. perfringens abundance prior to necrotizing enterocolitis, genomic analyses of 56 strains showing extensive virulence gene diversity, and clinical investigations linking toxin-producing strains to food poisoning, antibiotic-associated diarrhea, and enterocolitis, confirming its widespread presence across healthy and diseased hosts.

What were the most important findings?

The review found that Clostridium perfringens is a highly adaptable microbiome organism whose pathogenicity depends on toxin gene expression, microbiome disruption, and plasmid-mediated virulence. Major microbial associations showed that toxin-producing strains expand during microbiome dysbiosis, particularly following antibiotic exposure, allowing rapid proliferation due to its short generation time and spore-forming survival advantage. Genomic studies revealed an extremely diverse pangenome, with only 12.6% core genes, supporting extensive horizontal gene transfer and virulence adaptation. Enterotoxin (CPE), alpha toxin, beta toxin, and NetB toxin disrupt intestinal epithelial tight junctions, induce inflammation, and cause epithelial necrosis, driving food poisoning, antibiotic-associated diarrhea, and necrotizing enterocolitis. Microbiome studies showed that C. perfringens abundance increases significantly prior to necrotizing enterocolitis in pre-term infants, particularly when protective bacteria such as Bifidobacterium are reduced, confirming its role as a microbiome-linked disease biomarker.

What are the greatest implications of this review?

This review demonstrated that Clostridium perfringens acts as a microbiome-associated opportunistic pathogen whose virulence emerges during microbiome disruption, toxin gene activation, and antimicrobial selection pressure. Clinicians should recognize that disease risk depends on toxin-producing strains rather than simple colonization, and microbiome dysbiosis strongly influences pathogenic expansion. These findings highlight the importance of microbiome stability, toxin gene detection, and genomic surveillance in clinical diagnosis, and they support microbiome-targeted therapies, including probiotics and microbiota restoration, as potential strategies to prevent or reduce toxin-mediated intestinal disease.